210 related articles for article (PubMed ID: 19669262)
1. The effect of iron depletion on chronic hepatitis C virus infection.
Franchini M; Targher G; Capra F; Montagnana M; Lippi G
Hepatol Int; 2008 Sep; 2(3):335-40. PubMed ID: 19669262
[TBL] [Abstract][Full Text] [Related]
2. Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy.
Herrera JL
Am J Gastroenterol; 1999 Dec; 94(12):3571-5. PubMed ID: 10606321
[TBL] [Abstract][Full Text] [Related]
3. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
[TBL] [Abstract][Full Text] [Related]
4. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.
Fong TL; Han SH; Tsai NC; Morgan TR; Mizokami M; Qian D; Phan C; Goad K; Redeker AG
J Hepatol; 1998 Mar; 28(3):369-74. PubMed ID: 9551672
[TBL] [Abstract][Full Text] [Related]
5. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
Lecube A; Hernández C; Simó R
Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
[TBL] [Abstract][Full Text] [Related]
6. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
7. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.
Hörl WH; Schmidt A
Nephrol Dial Transplant; 2014 Jun; 29(6):1141-4. PubMed ID: 24286977
[TBL] [Abstract][Full Text] [Related]
8. [Significance of iron reduction for the therapy of chronic hepatitis C].
Nozić D; Balint B; Stanković N; Dimitrijević J; Nesković G
Vojnosanit Pregl; 2005 Feb; 62(2):161-4. PubMed ID: 15787170
[TBL] [Abstract][Full Text] [Related]
9. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C.
Fargion S; Fracanzani AL; Sampietro M; Molteni V; Boldorini R; Mattioli M; Cesana B; Lunghi G; Piperno A; Valsecchi C; Fiorelli G
Eur J Gastroenterol Hepatol; 1997 May; 9(5):497-503. PubMed ID: 9187884
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of phlebotomy on hepatitis C virus-associated musculoskeletal manifestations.
Hilzenrat N; Buskila D; Zilberman D; Sikuler E
Clin Rheumatol; 1998; 17(5):390-2. PubMed ID: 9805184
[TBL] [Abstract][Full Text] [Related]
11. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
Fontana RJ; Israel J; LeClair P; Banner BF; Tortorelli K; Grace N; Levine RA; Fiarman G; Thiim M; Tavill AS; Bonkovsky HL
Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565
[TBL] [Abstract][Full Text] [Related]
12. Phlebotomy improves histology in chronic hepatitis C males with mild iron overload.
Sartori M; Andorno S; Rossini A; Boldorini R; Bozzola C; Carmagnola S; Del Piano M; Albano E
World J Gastroenterol; 2010 Feb; 16(5):596-602. PubMed ID: 20128028
[TBL] [Abstract][Full Text] [Related]
13. Commentary: Iron metabolism in hepatitis C infection.
Roeckel IE
Ann Clin Lab Sci; 2000 Apr; 30(2):163-5. PubMed ID: 10807159
[TBL] [Abstract][Full Text] [Related]
14. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy.
Tsai NC; Zuckerman E; Han SH; Goad K; Redeker AG; Fong TL
Am J Gastroenterol; 1997 Oct; 92(10):1831-4. PubMed ID: 9382046
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.
Hino K; Nishina S; Sasaki K; Hara Y
Free Radic Biol Med; 2019 Mar; 133():193-199. PubMed ID: 30268888
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M
World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936
[TBL] [Abstract][Full Text] [Related]
17. Role of iron in the natural history and clinical course of hepatitis C disease.
Shedlofsky SI
Hepatogastroenterology; 1998; 45(20):349-55. PubMed ID: 9638405
[TBL] [Abstract][Full Text] [Related]
18. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
[TBL] [Abstract][Full Text] [Related]
19. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR
Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301
[TBL] [Abstract][Full Text] [Related]
20. Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome.
Sartori M; Andorno S; Rigamonti C; Boldorini R
Dig Liver Dis; 2001 Mar; 33(2):157-62. PubMed ID: 11346145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]